Inventor
NORMAN MARK H
US48 patents
⚠️ This page may combine multiple inventors who share the name “NORMAN MARK H”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AMGEN INC
34 patentsUS7560460B2Jul 14, 2009
Substituted piperazines and methods of use
AMGEN INC18 citations92
US7265138B2Sep 4, 2007
Vanilloid receptor ligands and their use in treatments
AMGEN INC48 citations92
US7053088B2May 30, 2006
Vanilloid receptor ligands and their use in treatments
AMGEN INC19 citations92
US6977264B2Dec 20, 2005
Substituted piperidines and methods of use
AMGEN INC26 citations92
US9066954B2Jun 30, 2015
Fused heterocyclic derivatives and methods of use
AMGEN INC22 citations91
US7928140B2Apr 19, 2011
Benzothiazole PI3 kinase modulators for cancer treatment
AMGEN INC32 citations91
US7820665B2Oct 26, 2010
Imidazopyridazine inhibitors of PI3 kinase for cancer treatment
AMGEN INC38 citations91
US6822097B1Nov 23, 2004
Compounds and methods of uses
AMGEN INC23 citations91
US7115607B2Oct 3, 2006
Substituted piperazinyl amides and methods of use
AMGEN INC42 citations90
US7429608B2Sep 30, 2008
Benzo[d]imidazol analogs as vanilloid receptor ligands and their use in treatments
AMGEN INC11 citations84
US8362241B2Jan 29, 2013
Inhibitors of PI3 kinase and/or mTOR
AMGEN INC11 citations83
US7687522B2Mar 30, 2010
Substituted pyridines and pyrimidines and their use in treatment of cancer
AMGEN INC8 citations83
US7119111B2Oct 10, 2006
2-oxo-1,3,4-trihydroquinazolinyl derivatives and methods of use
AMGEN INC11 citations82
US7144888B2Dec 5, 2006
Vanilloid receptor ligands and their use in treatments
AMGEN INC9 citations72
US8772480B2Jul 8, 2014
Inhibitors of PI3 kinase and/or mTOR
AMGEN INC5 citations71
US7915287B2Mar 29, 2011
Substituted heterocycles and methods of use
AMGEN INC4 citations62
US7439360B2Oct 21, 2008
Vanilloid receptor ligands and their use in treatments
AMGEN INC3 citations62
US7396831B2Jul 8, 2008
Vanilloid receptor ligands and their use in treatments
AMGEN INC5 citations62
US7390907B2Jun 24, 2008
Vanilloid receptor ligands and their use in treatments
AMGEN INC4 citations62
US7335672B2Feb 26, 2008
Vanilloid receptor ligands and their use in treatments
AMGEN INC6 citations62
US7534798B2May 19, 2009
Vanilloid receptor ligands and their use in treatments
AMGEN INC4 citations61
US7301022B2Nov 27, 2007
Vanilloid receptor ligands and their use in treatments
AMGEN INC4 citations61
US8026241B2Sep 27, 2011
Vanilloid receptor ligands and their use in treatments
AMGEN INC3 citations60
US7582761B2Sep 1, 2009
Vanilloid receptor ligands and their use in treatments
AMGEN INC2 citations60
US7544803B2Jun 9, 2009
Vanilloid receptor ligands and their use in treatments
AMGEN INC3 citations60
US7314933B2Jan 1, 2008
Vanilloid receptor ligands and their use in treatments
AMGEN INC1 citations52
US9550762B2Jan 24, 2017
Cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use
AMGEN INC1 citations51
US7524874B2Apr 28, 2009
Vanilloid receptor ligands and their use in treatments
AMGEN INC0 citations51
US7511044B2Mar 31, 2009
Vanilloid receptor ligands and their use in treatments
AMGEN INC1 citations50
US7332511B2Feb 19, 2008
Vanilloid receptor ligands and their use in treatments
AMGEN INC0 citations50
US7148221B2Dec 12, 2006
Vanilloid receptor ligands and their use in treatments
AMGEN INC1 citations50
US7709501B2May 4, 2010
Vanilloid receptor ligands and their use in treatments
AMGEN INC0 citations41
US9394297B2Jul 19, 2016
Amides as pim inhibitors
AMGEN INC0 citations38
US7553848B2Jun 30, 2009
Vanilloid receptor ligands and their use in treatments
AMGEN INC0 citations37
GUILFORD PHARM INC
3 patentsUS6331537B1Dec 18, 2001
Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds
GUILFORD PHARM INC59 citations96
US7078424B2Jul 18, 2006
N-linked sulfonamides of N-heterocyclic carboxylic acids or carboxylic acid isosteres
GUILFORD PHARM INC31 citations92
US7153883B2Dec 26, 2006
Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds
GUILFORD PHARM INC6 citations73